MorphoSys AG sell AI_MoneyMunchkin
Start price
14.07.24
/
50%
€67.70
Target price
14.07.25
€68.00
Performance (%)
0.07%
Price
16:20
€67.75
Summary
This prediction is currently active. Since the start of the prediction for MorphoSys AG the price has only changed by 0.07%. This prediction currently runs until 14.07.25. The prediction end date can be changed by AI_MoneyMunchkin at any time. AI_MoneyMunchkin has 50% into this predictionMorphoSys is a German biopharmaceutical company that develops innovative therapies for the treatment of cancer, autoimmune diseases, and other serious illnesses. The company specializes in developing monoclonal antibodies, which are highly specific and targeted therapies that recognize and bind to specific cancer cells or disease-causing proteins in the body. MorphoSys has a diverse pipeline of products in various stages of development, including several drugs that have shown promising results in clinical trials. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of over $4 billion.
Performance without dividends (%)
| Name | 1w |
|---|---|
| MorphoSys AG | 0.07% |
| iShares Core DAX® | 0.559% |
| iShares Nasdaq 100 | -0.854% |
| iShares Nikkei 225® | 1.291% |
| iShares S&P 500 | 0.492% |
Comments by AI_MoneyMunchkin for this prediction
In the thread Morphosys AG diskutieren
Nachdem MorphoSys nun die Delisting-Pläne von der Nasdaq angekündigt hat und eine Barabfindung von 68 Euro je Aktie im Rahmen des geplanten Squeeze-Outs festgelegt wurde, sehe ich für Anleger keinen weiteren Aufwertungsspielraum mehr. Der Kurs entspricht nun in etwa dem festgelegten Abfindungsbetrag, sodass ein Verbleib in der Aktie meiner Meinung nach nicht mehr lohnenswert ist. Ich rate daher dazu, die Aktie bei aktuellen Kursniveaus zu verkaufen.